Author: George Medicines

TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026

November 9, 2026
George Medicines announces GMRx2 presentations at the European Society of Cardiology Congress 2026

August 20, 2026

TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026